Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 12Terminated 2Withdrawn 1Unknown 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Myeloid 2Plasma cell 1Other hematologic neoplasm 1Lymphoid 1Classical hematology 1

Conditions

Leukemia, Myeloid, Acute 30Myelodysplastic Syndromes 22Precursor Cell Lymphoblastic Leukemia-Lymphoma 19Leukemia 17Multiple Myeloma 13Lymphoma, Non-Hodgkin 13Leukemia, Myelogenous, Chronic, BCR-ABL Positive 12Leukemia, Lymphocytic, Chronic, B-Cell 12Lymphoma 11Hodgkin Disease 11Myeloproliferative Disorders 9Congenital Abnormalities 9Neoplasms, Plasma Cell 8Leukemia, Myeloid, Accelerated Phase 8Blast Crisis 8Lymphoma, Large B-Cell, Diffuse 7Lymphoma, Follicular 7Leukemia, Myelomonocytic, Chronic 7Leukemia, Myeloid, Chronic-Phase 7Primary Myelofibrosis 6Myelodysplastic-Myeloproliferative Diseases 6Lymphoma, Mantle-Cell 6Lymphoma, B-Cell, Marginal Zone 6Leukemia, Myelomonocytic, Juvenile 6Lymphoma, Large-Cell, Immunoblastic 5Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 5Hematologic Neoplasms 5Graft vs Host Disease 5Burkitt Lymphoma 5Sezary Syndrome 4

Interventions

fludarabine phosphate 4Cyclosporine 3Cyclophosphamide 311-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene 3ruxolitinib 2fludarabine 2Whole-Body Irradiation 2Stem Cell Transplantation 2Radiotherapy 2Methylprednisolone 2Busulfan 2Antilymphocyte Serum 2nelarabine 1arsenous acid 1anagrelide 1Watchful Waiting 1Thiotepa 1Tetradecanoylphorbol Acetate 1Surveys and Questionnaires 1Peripheral Blood Stem Cell Transplantation 1Oxycodone 1Observation 1N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide 1Mycophenolic Acid 1Moxifloxacin 1Morphine 1Methotrexate 1Methadone 1Liposomes 1Leucovorin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × Thrombocythemia, Essential × Busulfan × Clear all
NCT02410551 2018-10-30

Pacritinib Before Transplant for Myeloproliferative Neoplasms (MPN)

M.D. Anderson Cancer Center

Phase 2 Terminated
4 enrolled 5 charts
Myeloid

Myeloproliferative Disorders, Polycythemia Vera, Thrombocythemia, Essential, Primary Myelofibrosis

NCT00005641 2012-12-11

Removal of T Cells to Prevent Graft-Versus-Host Disease in Patients Undergoing Bone Marrow Transplantation

H. Lee Moffitt Cancer Center and Research Institute

Phase 2 Terminated
Classical hematologyLymphoidMyeloidOther hematologic neoplasmPlasma cell

Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, Blast Crisis, Graft vs Host Disease, Leukemia, Multiple Myeloma, Myelodysplastic Syndromes, Myeloproliferative Disorders, Polycythemia Vera, Thrombocythemia, Essential, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Neoplasms, Plasma Cell, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡